Global Infection Control Market 2020-2024 | Evolving Opportunities with 3M Co. and Astellas Pharma Inc. | Technavio
LONDON--(BUSINESS WIRE)--Nov 20, 2019--
Technavio has been monitoring the global infection control market and the market is poised to grow by USD 29.49 billion during 2020-2024 at a CAGR of over 4% during the forecast period. Request Free Sample Pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191120005519/en/
Technavio has announced its latest market research report titled global infection control market 2020-2024 (Graphic: Business Wire)
Read the 155-page research report with TOC on “Infection Control Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Type (Therapeutic and Non-therapeutic), and Segment Forecasts, 2020-2024”.
The market is driven by the growing geriatric population. In addition, technological advances in sterilizing equipment are anticipated to further boost the growth of the infection control market.
The geriatric population is highly susceptible to infectious diseases. The incidence depends on the site of infection and location of the patient, whether a hospital, nursing home or community. Patients residing in nursing homes are mostly affected by pressure ulcer infections, urinary tract infection, and pneumonia. In addition, the chances of acquiring nosocomial infections are high among hospitalized elderly patients. Thus, the growth in the geriatric population is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Infection Control Market Companies:
3M Co. is headquartered in the US and operates the business under various segments such as Industrial, Safety and graphics, Health care, Electronics and energy, and Consumer. The company offers a broad range of sterilizers.
Astellas Pharma Inc.
Astellas Pharma Inc. is headquartered in Japan and offers products through the business unit: Pharmaceuticals. The company offers products such as Sawacillin and Flemoclav Solutab.
Cantel Medical Corp.
Cantel Medical Corp. is headquartered in the US and operates under various business segments, namely Medical, Life sciences, Dental, and Dialysis. The company offers Dry Fog equipment and REVOX sterilization systems and services.
Ecolab Inc. is headquartered in the US and offers products through the following business segments: Global industrial, Global institutional, Global energy, and Other. The company offers OxyCide, which is used as a daily disinfectant cleaner.
Getinge AB is headquartered in Sweden and offers products through the following business segments: Acute care therapies, Life science, and Surgical workflows. The company offers Getinge 86-series products.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
Infection Control Type Outlook (Revenue, USD Million, 2020-2024)
Infection Control Regional Outlook (Revenue, USD Million, 2020-2024)
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Related Reports on Health Careinclude:
Infection Surveillance Solutions Market – Global Infection Surveillance Solutions Market by geography (Asia, Europe, North America, and ROW) and solution (software and services).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191120005519/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: INFECTIOUS DISEASES PHARMACEUTICAL HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 11/20/2019 08:51 AM/DISC: 11/20/2019 08:51 AM